mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.31 |
2e-10 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-08 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.27 |
3e-07 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |